Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q4 2025

Type / Class
Equity / Voting Common Stock, par value $0.0001 per share
Symbol
JSPR on Nasdaq
Shares outstanding
28,086,431
Price per share
$1.53
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
19,220,734
Total reported value
$35,163,686
% of total 13F portfolios
0%
Share change
-5,665
Value change
-$2,365,311
Number of holders
53
Price from insider filings
$1.53
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Velan Capital Investment Management LP 9.6% $7,578,242 2,668,395 Velan Capital Investment Management LP 19 Sep 2025
T. Rowe Price Investment Management, Inc. 7.1% $4,897,117 2,057,612 T. Rowe Price Investment Management, Inc. 30 Sep 2025
MORGAN STANLEY 7% +140% $3,269,843 +$1,967,361 1,969,785 +151% Morgan Stanley 31 Dec 2025
GOLDMAN SACHS GROUP INC 6.3% $2,929,648 1,764,848 THE GOLDMAN SACHS GROUP, INC. 31 Dec 2025
INTEGRATED CORE STRATEGIES (US) LLC 5.8% $2,492,390 1,629,013 Millennium Management LLC 18 Feb 2026
Soleus Capital Master Fund, L.P. 10% $7,068,607 1,494,420 Soleus Capital Management, L.P. 31 Dec 2024
ACORN BIOVENTURES, L.P. 5.3% -18% $2,660,821 -$537,000 1,486,492 -17% Anders Hove 23 Jan 2026
KINGDON CAPITAL MANAGEMENT, L.L.C. 4.7% -8% $3,153,131 +$1,332,431 1,324,845 +73% Kingdon Capital Management, L.L.C. 30 Sep 2025
Carlyle Group Inc. 3.8% $1,665,114 1,088,310 The Carlyle Group Inc. 18 Feb 2026
Qiming U.S. Healthcare Fund II, L.P. 3.3% $2,210,934 928,964 Qiming U.S. Healthcare Fund II, L.P. 30 Sep 2025
BlackRock, Inc. 1.5% $1,252,311 225,605 BlackRock, Inc. 30 Jun 2025

As of 31 Dec 2025, 53 institutional investors reported holding 19,220,734 shares of Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR). This represents 68% of the company’s total 28,086,431 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR) together control 67% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Velan Capital Investment Management LP 9.5% 2,668,395 0% 2.8% $4,883,163
MORGAN STANLEY 7% 1,969,785 +149% 0% $3,604,707
ACORN CAPITAL ADVISORS, LLC 6.4% 1,786,492 +29% 1.1% $3,269,280
GOLDMAN SACHS GROUP INC 6.2% 1,746,492 +6395% 0% $3,196,080
VANGUARD GROUP INC 4.7% 1,326,512 +28% 0% $2,427,518
Rock Springs Capital Management LP 3.9% 1,100,726 0% 0.1% $2,014,329
MILLENNIUM MANAGEMENT LLC 3.8% 1,073,783 +194% 0% $1,965,023
Carlyle Group Inc. 3.8% 1,066,189 0% 0.01% $1,940,464
Woodline Partners LP 3.7% 1,040,704 +0.09% 0.01% $1,904,488
T. Rowe Price Investment Management, Inc. 3.4% 964,754 -6.2% 0% $1,766,000
BOOTHBAY FUND MANAGEMENT, LLC 2.8% 793,954 +79% 0.04% $1,452,936
SPHERA FUNDS MANAGEMENT LTD. 1.7% 485,401 -23% 0.19% $888,284
Lion Point Capital, LP 1.7% 465,000 +17% 4.4% $850,950
BANK OF AMERICA CORP /DE/ 1% 293,027 -0.52% 0% $536,239
Squarepoint Ops LLC 1% 281,926 +1920% 0% $515,925
BlackRock, Inc. 0.84% 236,224 +15% 0% $432,290
RENAISSANCE TECHNOLOGIES LLC 0.81% 227,183 +9% 0% $415,745
GEODE CAPITAL MANAGEMENT, LLC 0.75% 211,857 +62% 0% $387,788
Soleus Capital Management, L.P. 0.71% 200,000 -87% 0.02% $366,000
Knott David M Jr 0.65% 181,389 +5.8% 0.15% $331,942
ADAR1 Capital Management, LLC 0.5% 140,000 0.02% $256,200
UBS Group AG 0.45% 126,361 +221% 0% $231,240
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.37% 104,787 +194% 0% $191,760
Quarry LP 0.35% 99,529 0.04% $182,138
READYSTATE ASSET MANAGEMENT LP 0.35% 98,439 0% 0.01% $180,143

Institutional Holders of Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 19,220,734 $35,163,686 -$2,365,311 $1.83 53
2025 Q3 20,155,363 $47,814,871 +$13,375,645 $2.38 60
2025 Q2 12,514,434 $69,456,410 -$2,535,024 $5.55 63
2025 Q1 13,034,173 $56,047,183 -$70,633,595 $4.30 66
2024 Q4 15,646,434 $334,368,683 +$15,008,656 $21.38 84
2024 Q3 14,676,954 $274,620,688 -$5,485,865 $18.81 77
2024 Q2 14,557,013 $329,580,756 +$34,893,415 $22.70 67
2024 Q1 12,950,959 $379,146,145 +$364,621,578 $29.36 56
2023 Q4 494,706 $390,323 +$390,323 $0.79 1